Those are the types of clues Eli Lillys CEO, David Ricks, says his company will pursue next year, testing whether its GLP-1 drug, tirzepatide (called Mounjaro for diabetes treatment, and Zepbound for weight loss), could help with addiction to alcohol, nicotine, and other things we dont think about [as being] connected to weight. In comments he made in December, Ricks said the drugs might be anti-hedonicsmeaning they counteract our hedonistic pursuit of pleasure, be it from food, alcohol, or drugs
Get back to being you, with weight loss through Compounded GLP-1 Therapy
GLUCAGON-LIKE PEPTIDE RECEPTOR AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR AGONISTS These medications act by mimicking endogenous incretins peptide hormones secreted by the gastrointestinal system, controlled by neural mechanisms
Are GLP-1 treatments safe
Yes, every medication has potential side effects and health risks, and these drugs are no different in that regard